Link Technologies Licenses Agilent's RNA Monomers

May 15, 2009

NEW YORK (GenomeWeb News) – Link Technologies has licensed Agilent Technologies' RNA monomers technology, the Scottish company said today.

Link Technologies said it will manufacture and sell the four RNA monomer phosphoramidite reagents for use in research.

The company makes reagents for oligonucleotide synthesis and modification, and it offers a variety of products including phosphoramidites, solid supports, modifiers, labels, bioconjugation and oligo-immobilisation products.

Financial terms of the agreement were not released.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

Cloud Ready

CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.

The New Yeast

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

The Science and Policy Connection

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

This Week in Cell

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.

Main menu